Lipitor R.I.P. Infographic
Search This Blog
About Me
- PharmaGuy
- Pharmaguy™ (@pharmaguy) – also known as John Mack – is the Publisher and Editor of Pharma Marketing News, an independent monthly electronic newsletter focused on issues of importance to pharmaceutical marketing executives.
These are my personal opinions, some of which are also published as articles in Pharma Marketing News with more details.
Subscribe to the newsletter for more detailed coverage of pharma marketing issues, product reviews and coverage of pharma industry conferences – much of it based upon interviews with experts in the field of pharmaceutical marketing.
I am not a paid consultant to the pharmaceutical industry, but I occasionally get invited to speak within pharma companies or at industry conferences. For this I receive reimbursement for travel expenses and a nominal speaker fee. As a publisher, I do accept paid advertising mostly from agencies that work for the pharmaceutical industry.
If you would like to send me an email, try this: pharmaguy@pharmaguy.com
Subscribe to My Feedburner NewsfeedSubscribe To
Posts
Comments
Followers
Pharma Marketing Talk Show
Labels
#fdasm
Ad Spend
ADHD
Adherence
Adverse events
AstraZeneca
Avandia
Awards
BadAd
Bayer
BMS
Boehringer
Boehringer Ingelheim
Botox
Buzz/Public Relations/Image
Celebrity Endorsement
Chantix
CME
Crestor
Cymbalta
Diddies and Spoofs
Disease awareness
Disease Mongering
Drug prices
Drug Safety
DTC Advertising
eMarketing
FaceBook
FDA
Gardasil
Gifts to Physicians
Google
GSK
Guidance
Johnson and Johnson
Legal/Regulatory
Lilly
Lipitor
Lunesta
marketing mix
Medical Devices
Mobile
Novartis
Novo Nordisk
Obesity drugs
off-label promotion
Pfizer
Pharma Marketing Talk
PhRMA
Physician Education
Physician Marketing
Physician Sunshine Act
Pinterest
Print DTC
Regulation
Reminder Ads
Risk Communication
Rozerem
Sales and Sales Reps
sanofi-aventis
Schering-Plough
Sexual Performance Drugs
Sleep Aid Drugs
social media
social media marketing
social networking
Twitter
Unbranded Advertising
Viagra
Vytorin
YAZ
YouTube
Popular Posts From Last 30 Days
-
Have you noticed a recent deterioration in your ability to play sports? Are you falling asleep after dinner? Those are just two of the que... -
"Be heard!", says Allergan. "The voices of 250,000 can influence the dialogue on the obesity epidemic and help shape policies... -
There are no Big Pharma CEOs that I know of who actively and directly engage with their stakeholders -- investors, physicians, patients --... -
The U.S. Justice Department announced yesterday that it has filed a second civil false claims lawsuit against Novartis Pharmaceuticals Corp.... -
Today, I posted on Twitter "HCP digital spend by pharma to equal that of print this year, forecast says." That tweet is getting a ... -
Over the months I have reviewed several of Pfizer's digital and social media efforts and have said that the company is good at promo... -
"How can Merck look itself in the mirror?", asks Josh Bloom of the American Council for Science and Health (see here ). "... -
PharmaGuy (aka John Mack, me) will present at the Roche "Digital Academy" in June, 2013. The Digital Academy is a project that has... -
This is the adherence season for pharma industry conferences. This Monday and Tuesday was the 12th Annual Patient Adherence and Support Summ...
-
According to Gideon Mantel, co-founder and CEO of Treato, social media can predict the success of a new drug launch much faster than traditi...
Pharmaguy™'s Picks
My Tweets
Tweets by Pharma Execs
Looks like these Big Pharma's really good in advertisement. Now they are questioning that exercise and healthy diet are enough to lower cholesterol. What about their products? Why don't they tell statins side effects? they should if they really care.
ReplyDelete